documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
23 rows where docket_id = "FDA-2001-E-0027" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: title, subtype, posted_date, posted_month, comment_start_date, last_modified, open_for_comment, posted_date (date), comment_start_date (date), last_modified (date)
document_type 3
agency_id 1
- FDA 23
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2001-E-0027-0023 | FDA | Angiomax, Patent Term Extension Application, No. 5,196,404 FDA-2001-E-0027 | U.S. Patent and Trademark Office to Wilmer Cutler Pickering Hale and Dorr LLP - Letter | Other | Letter(s) | 2012-06-05T04:00:00Z | 2012 | 6 | 2012-06-05T04:00:00Z | 2012-06-05T12:42:13Z | 0 | 0 | 0900006481034550 | ||
| FDA-2001-E-0027-0022 | FDA | Angiomax, Patent Term Extension Application, No. 5,196,404 FDA-2001-E-0027 | Letter to U. S. Patent and Trademark Office | Other | Letter(s) | 2012-04-03T04:00:00Z | 2012 | 4 | 2012-04-03T04:00:00Z | 2024-03-13T18:08:18Z | 0 | 0 | 0900006480fe7a63 | ||
| FDA-2001-E-0027-0021 | FDA | Angiomax, Patent Term Extension Application, No. 5,196,404 FDA-2001-E-0027 | FDA/CDER to United States Patent and Trademark Office - Letter | Other | Letter(s) | 2011-08-09T04:00:00Z | 2011 | 8 | 2011-08-09T04:00:00Z | 2011-08-09T18:55:22Z | 0 | 0 | 0900006480edc64a | ||
| FDA-2001-E-0027-0020 | FDA | Angiomax, Patent Term Extension Application, No. 5,196,404 FDA-2001-E-0027 | Determinations of Regulatory Review Periods for Purposes of Patent Extensions: ANGIOMAX | Notice | N-Notice | 2010-12-16T05:00:00Z | 2010 | 12 | 2010-12-16T05:00:00Z | 2024-11-12T05:00:23Z | 2010-31583 | 1 | 0 | 0900006480bb825a | |
| FDA-2001-E-0027-0019 | FDA | Angiomax, Patent Term Extension Application, No. 5,196,404 FDA-2001-E-0027 | FDA/CDER to U.S. Patent and Trademark Office - Letter | Other | LET-Letter | 2010-11-24T05:00:00Z | 2010 | 11 | 2010-11-24T05:00:00Z | 2010-11-24T13:39:34Z | 0 | 0 | 0900006480ba28ee | ||
| FDA-2001-E-0027-0018 | FDA | Angiomax, Patent Term Extension Application, No. 5,196,404 FDA-2001-E-0027 | U.S. Patent & Trademark Office to Wilmer Cutler Pickering Hale and Dorr LLP - Letter | Other | LET-Letter | 2010-09-14T04:00:00Z | 2010 | 9 | 2010-09-14T04:00:00Z | 2013-07-27T23:30:50Z | 0 | 0 | 0900006480b4edf1 | ||
| FDA-2001-E-0027-0017 | FDA | Angiomax, Patent Term Extension Application, No. 5,196,404 FDA-2001-E-0027 | US Patent and Trademark Office to Wilmer Cutler Pickering Hale and Dorr LLP - Denial of Application | Other | ADN-Denial of Application | 2010-04-01T04:00:00Z | 2010 | 4 | 2013-08-11T01:33:32Z | 0 | 0 | 0900006480acd82c | |||
| FDA-2001-E-0027-0016 | FDA | Angiomax, Patent Term Extension Application, No. 5,196,404 FDA-2001-E-0027 | The Medicines Company v. USPTO, FDA, and DHHS, No. 1:10cv81-CMH/TCB, in the United States District Court for the Eastern District of Virginia (Alexandria Division), January 27, 2010 - Background Material | Supporting & Related Material | BKG-Background Material | 2010-02-16T05:00:00Z | 2010 | 2 | 2010-04-01T13:04:43Z | 0 | 0 | 0900006480aa5857 | |||
| FDA-2001-E-0027-0015 | FDA | Angiomax, Patent Term Extension Application, No. 5,196,404 FDA-2001-E-0027 | U.S. Patent & Trademark Office to The Medicine Company, November 20, 2001 re Notice of Final Determination - Letter | Other | CP-Citizen Petition | 2010-02-02T05:00:00Z | 2010 | 2 | 2013-07-27T23:05:51Z | 0 | 0 | 0900006480a8ba8a | |||
| FDA-2001-E-0027-0012 | FDA | Angiomax, Patent Term Extension Application, No. 5,196,404 FDA-2001-E-0027 | U.S. Patent & Trademark Office to FDA/CDER - Letter | Other | LET-Letter | 2010-02-01T05:00:00Z | 2010 | 2 | 2010-02-01T05:00:00Z | 2013-08-11T03:06:37Z | 0 | 0 | 0900006480a88cb0 | ||
| FDA-2001-E-0027-0011 | FDA | Angiomax, Patent Term Extension Application, No. 5,196,404 FDA-2001-E-0027 | The Medicines Company (Fish & Neave) - Application for Patent Extension Term | Other | APP-Application | 2010-02-01T05:00:00Z | 2010 | 2 | 2010-02-01T05:00:00Z | 2013-07-27T21:00:00Z | 0 | 0 | 09000064804b5c99 | ||
| FDA-2001-E-0027-0014 | FDA | Angiomax, Patent Term Extension Application, No. 5,196,404 FDA-2001-E-0027 | U.S. Patent & Trademark Office to The Medicine Company, March 2, 2002 re Corrected Notice of Final Determination - Letter | Other | LET-Letter | 2010-02-01T05:00:00Z | 2010 | 2 | 2010-02-01T05:00:00Z | 2013-07-27T23:05:43Z | 0 | 0 | 0900006480a88ef2 | ||
| FDA-2001-E-0027-0013 | FDA | Angiomax, Patent Term Extension Application, No. 5,196,404 FDA-2001-E-0027 | Blank Rome, LLP to FDA/CDER - Letter | Other | LET-Letter | 2010-02-01T05:00:00Z | 2010 | 2 | 2010-02-01T05:00:00Z | 2013-07-27T23:05:43Z | 0 | 0 | 0900006480a88cb3 | ||
| FDA-2001-E-0027-0006 | FDA | Angiomax, Patent Term Extension Application, No. 5,196,404 FDA-2001-E-0027 | U.S. Patent & Trademark Office to FDA/CDER - Letter | Other | LET-Letter | 2009-04-16T04:00:00Z | 2009 | 4 | 2009-04-16T04:00:00Z | 2010-01-29T15:47:40Z | 0 | 0 | 09000064804b5cb1 | ||
| FDA-2001-E-0027-0007 | FDA | Angiomax, Patent Term Extension Application, No. 5,196,404 FDA-2001-E-0027 | FDA/CDER to Dockets Management - Memorandum | Other | M-Memorandum | 2009-04-16T04:00:00Z | 2009 | 4 | 2009-04-16T04:00:00Z | 2010-01-29T15:50:37Z | 0 | 0 | 09000064804b5cb3 | ||
| FDA-2001-E-0027-0010 | FDA | Angiomax, Patent Term Extension Application, No. 5,196,404 FDA-2001-E-0027 | Generamedix Pharmaceuticals, Inc. - Citizen Petition | Other | CP-Citizen Petition | 2009-04-16T04:00:00Z | 2009 | 4 | 2009-04-16T04:00:00Z | 2009-04-16T22:01:01Z | 0 | 0 | 09000064804b5cbb | ||
| FDA-2001-E-0027-0008 | FDA | Angiomax, Patent Term Extension Application, No. 5,196,404 FDA-2001-E-0027 | Envelope - [Generamedix Pharmaceuticals, Inc., (Blank Rome, LLP) - Citizen Petition] | Supporting & Related Material | CP-Citizen Petition (Supporting & Related Materials) | 2009-04-16T04:00:00Z | 2009 | 4 | 2010-01-29T16:04:18Z | 0 | 0 | 09000064804b5cb8 | |||
| FDA-2001-E-0027-0009 | FDA | Angiomax, Patent Term Extension Application, No. 5,196,404 FDA-2001-E-0027 | Generamedix Pharmaceuticals, Inc., (Blank Rome, LLP) - Withdrawal | Other | WDL-Withdrawal | 2009-04-16T04:00:00Z | 2009 | 4 | 2009-04-16T04:00:00Z | 2013-07-27T21:00:00Z | 0 | 0 | 09000064804b5cc7 | ||
| FDA-2001-E-0027-0005 | FDA | Angiomax, Patent Term Extension Application, No. 5,196,404 FDA-2001-E-0027 | FDA/CDER to the U.S. Patent and Trademark Office - Letter | Other | LET-Letter | 2006-11-02T05:00:00Z | 2006 | 11 | 2009-04-16T21:37:40Z | 0 | 0 | 09000064804b5cc2 | |||
| FDA-2001-E-0027-0004 | FDA | Angiomax, Patent Term Extension Application, No. 5,196,404 FDA-2001-E-0027 | Acknowledgement Letter to Generamedix Pharmaceuticals, Inc. - Correction | Other | CR-Correction | 2006-10-23T04:00:00Z | 2006 | 10 | 2010-01-29T15:42:31Z | 0 | 0 | 09000064804b5cc0 | |||
| FDA-2001-E-0027-0002 | FDA | Angiomax, Patent Term Extension Application, No. 5,196,404 FDA-2001-E-0027 | Acknowledgement Letter to Generamedix Pharmaceuticals, Inc. | Other | ACK-Acknowledgement Letter | 2006-10-18T04:00:00Z | 2006 | 10 | 2010-01-29T15:38:18Z | 0 | 0 | 09000064804b5cb6 | |||
| FDA-2001-E-0027-0003 | FDA | Angiomax, Patent Term Extension Application, No. 5,196,404 FDA-2001-E-0027 | FDA-2001-E-0027-0002 | Supporting & Related Material | ACK-Acknowledgement Letter (Supporting and Related Material) | 2006-10-18T04:00:00Z | 2006 | 10 | 2010-01-29T15:36:58Z | 0 | 0 | 09000064804b5cbd | |||
| FDA-2001-E-0027-0001 | FDA | Angiomax, Patent Term Extension Application, No. 5,196,404 FDA-2001-E-0027 | FDA/CDER to the U. S. Patent & Trademark Office - Letter | Other | LET-Letter | 2001-09-12T04:00:00Z | 2001 | 9 | 2010-01-29T15:43:16Z | 0 | 0 | 09000064804b5c4f |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);